Co-crystals of boscalid and triazoles

ABSTRACT

The present invention relates to co-crystals of boscalid and a triazole fungicide such as hexaconazole or cyproconazole. Also included are agrochemical compositions and methods of combating or controlling fungi by contacting the fungi or their locus with a fungicidally effective amount of the co-crystal.

CROSS REFERENCE TO RELATED APPLICATIONS

This application is a divisional of U.S. application Ser. No. 16/772,376filed on Jun. 12, 2020, which is a National Stage application ofPCT/IB/2018/060147, filed Dec. 15, 2018, which claims the benefit ofIndian Application No. 201731045819, filed Dec. 20, 2017, all of whichare incorporated by reference in their entirety herein.

TECHNICAL FIELD OF THE INVENTION

The present invention relates to co-crystals of boscalid with triazoles,a process for the preparation of the same, compositions comprising theco-crystal and to a method of controlling fungi using said compositions.

BACKGROUND

Triazole fungicides are sterol demethylation inhibitors. These compoundsare highly efficient broad-spectrum fungicides. Triazoles are systemicfungicides with protective, curative and eradicative action. Thesefungicides are used on different types of plants including field crops,fruit trees, small fruit, vegetables, and turf. These fungicides arehighly effective against different fungal diseases. Due to the wideapplication and effective control over various fungal disease, thesecompounds are preferred in agricultural industry.

However, most of the triazole fungicide liquid formulations exhibitcrystal growth during storage and handling. Due to fluctuations intemperature the smaller crystals of triazoles tend to form largercrystals i.e., the smaller crystals dissolve and recrystallize intolarger crystals. The formation of large particles is thermodynamicallyfavored as they are energetically more stable than the smaller ones.Hence there is problem to achieve desired storage stability in triazoleformulations due to such particle size growth. Moreover, these largecrystals block the spray nozzles during application of the formulation.

Various approaches have been adopted to prevent the crystal formation,e.g., use of solvents, surfactants or crystal growth inhibitors.

However, the problem of crystal formation still needs to be addressed.

WO2007028387 discloses concentrated liquid formulations comprisingtriazole fungicides. The solvents are selected among esters of plantoils, water-miscible polar aprotic co-solvents, water-immiscibleco-solvents and surfactants to solve the problem of crystallization intriazole fungicide liquid formulations.

US2002040044 discloses the use of a tristyrylphenol-ethoxylate or itssulfate or phosphate, in combination with either vinylpyrrolidonehomopolymer, or vinylpyrrolidone/styrene block polymer, or a hydrophilicethylene oxide-propylene oxide block polymer, or with a mixture thereoffor the prevention of crystal growth of the triazole fungicide onstorage of the suspension concentrates.

However, all the crystallization inhibitors and surfactants mentioned inthe prior art are expensive and not environmentally favorable.

In recent years co-crystallization is widely used technique forimproving stability of pesticidal formulations. Co-crystals are definedas “solids that are crystalline materials composed of two or moremolecules in the same crystal lattice”. Co-crystals can be made from twoor more different active ingredients or with one or more actives withother co-formers. These compounds can be formed by intermolecular forcessuch as hydrogen bonding, π-stacking and van der Waal's forces.Co-crystals may alter or enhance several important physico-chemicalcharacteristics of the substances like solubility, bioavailability,stability, hygroscopicity, morphology, filtration and flow ability.These properties have a huge influence on pesticide formulation.

Boscalid is a Succinate De-Hydrogenase Inhibitor fungicide. It is afoliar fungicide, with translaminar and acropetal movement within theplant leaf, providing preventive and, in some cases, curative action.Boscalid inhibits spore germination, germ tube elongation and is alsoeffective on all other stages of fungal development.

Surprisingly inventors of the present invention found out co-crystals ofboscalid and triazoles do not exhibit crystal formation in a formulationin storage conditions.

OBJECTS OF THE INVENTION

It is an object of the invention to provide a co-crystal of boscalidwith triazole.

It is an object of the invention to provide formulations comprisingco-crystal of boscalid and triazole.

SUMMARY OF THE INVENTION

The present invention provides co-crystal of boscalid and a triazole.

Further it relates to a process for preparation of co-crystal ofboscalid and a triazole.

The present invention further relates to agrochemical compositionscomprising co-crystal of boscalid and a triazole.

In another aspect there is provided a method of using co-crystal ofboscalid and a triazole for effectively controlling fungi.

DETAILED DESCRIPTION OF THE INVENTION

The inventors of the present invention surprisingly found out thatboscalid forms a co-crystal with triazoles.

In the context of the present invention the term ‘co-crystals’ isdefined as “solids that are crystalline materials composed of two ormore molecules in the same crystal lattice”.

The present invention provides co-crystals of boscalid and triazole.

Further there is provided a process for the preparation of co-crystal ofboscalid and triazoles.

In an aspect, present invention provides agrochemical compositionscomprising co-crystal of boscalid and triazoles.

In an embodiment, the triazole fungicide is selected from cyproconazole,difenoconazole, epoxiconazole, flutriafol, hexaconazole,mefentrifluconazole, prothioconazole, tebuconazole, tetraconazole andtriticonazole.

Thus, in an aspect, the present invention provides co-crystal ofboscalid and a triazole selected from cyproconazole, difenoconazole,epoxiconazole, flutriafol, hexaconazole, mefentrifluconazole,prothioconazole, tebuconazole, tetraconazole and triticonazole.

In another aspect, the present invention provides a process forpreparation of co-crystal of boscalid and a triazole selected fromcyproconazole, difenoconazole, epoxiconazole, flutriafol, hexaconazole,mefentrifluconazole, prothioconazole, tebuconazole, tetraconazole andtriticonazole.

In another aspect, the present invention provides agrochemicalcompositions comprising co-crystal of boscalid and a triazole selectedfrom cyproconazole, difenoconazole, epoxiconazole, flutriafol,hexaconazole, mefentrifluconazole, prothioconazole, tebuconazole,tetraconazole and triticonazole.

In another aspect, the present invention provides a method of usingco-crystal of boscalid and a triazole for effectively controlling fungi,wherein the triazole is selected from cyproconazole, difenoconazole,epoxiconazole, flutriafol, hexaconazole, mefentrifluconazole,prothioconazole, tebuconazole, tetraconazole and triticonazole.

In an embodiment, the preferred triazole fungicide is tebuconazole.

Thus, in an embodiment, the present invention provides a co-crystal ofboscalid and tebuconazole.

In an embodiment, the present invention provides co-crystal of boscalidand tebuconazole characterized by the co-crystal having a melting pointbetween about 90-97° C. when measured in Differential ScanningCalorimeter.

In an embodiment, the molar ratio of boscalid and tebuconazole may varyin the range about 10:1 to 1:10, particularly from 1:3 to 3:1,especially 1:1.

In an embodiment, the molar ratio of co-crystal of boscalid andtebuconazole is 1:1.

In an embodiment, the present invention provides a process forpreparation of co-crystal of boscalid and tebuconazole.

In another embodiment, the present invention provides an agrochemicalcomposition comprising co-crystal of boscalid and tebuconazole.

In another embodiment, there is provided a method of using co-crystal ofboscalid and tebuconazole for effectively controlling fungi.

In an embodiment, the present invention provides a co-crystal ofboscalid and hexaconazole.

In another embodiment, the present invention provides co-crystal ofboscalid and hexaconazole characterized by the co-crystal having amelting point between 101-105° C. when measured in Differential ScanningCalorimeter.

In an embodiment, the molar ratio of boscalid and hexaconazole in theco-crystal may vary in the range about 10:1 to 1:10, particularly from1:3 to 3:1, especially 1:1.

In a preferred embodiment, the co-crystal structures described hereincomprise boscalid and hexaconazole in about 1:1 molar ratio.

In an embodiment, the present invention provides a co-crystal ofboscalid and cyproconazole.

In an embodiment, the present invention provides co-crystal of boscalidand cyproconazole characterized by the co-crystal having a melting pointbetween 97-101° C. when measured in Differential Scanning Calorimeter.

In an embodiment, the molar ratio of boscalid and cyproconazole may varyin the range about 10:1 to 1:10, particularly from 1:3 to 3:1,especially 1:1.

In a preferred embodiment, the co-crystal structures described hereincomprise boscalid and cyproconazole in about 1:1 molar ratio.

In an embodiment of the present invention the co-crystal of boscalid anda triazole can be obtained by any conventional process known to theperson skilled in the art used to prepare such co-crystals.

The co-crystal of boscalid and a triazole can be prepared by solutioncrystallization, dry grinding, and solvent drop grinding technique.

In an embodiment, the present invention provides a process for thepreparation of co-crystal of boscalid and a triazole comprising:

-   -   a) preparing a concentrated solution of boscalid and a triazole        in a one or more solvents;    -   b) triturating or precipitating with an anti-solvent to obtain        the co-crystal.

In another embodiment, the present invention provides a process for thepreparation of co-crystal of boscalid and a triazole comprising:

-   -   a) preparing a concentrated solution of boscalid and a triazole        in a one or more solvents;    -   b) optionally evaporating the solvent;    -   c) triturating or precipitating with an anti-solvent to obtain        the co-crystal.

According to an embodiment the solvent can be selected from aliphaticalcohols, ketones, esters, ethers, polar protic solvents, polar aproticsolvents, halogenated solvents, aliphatic hydrocarbon, and aromatichydrocarbon.

According to an embodiment the solvent can be selected from methanol,ethanol, isopropyl alcohol, acetone, dichloromethane, dichloroethane,dichloropropane, trichloroethane, chloroform, and ethyl acetate.

In an embodiment of the present invention the anti-solvent can bealiphatic or aromatic hydrocarbon.

In an embodiment in step (b) the solvent is partially evaporated.

In an embodiment in step (b) the solvent is completely evaporated.

In a preferred embodiment of the present invention, the anti-solvent isselected from n-hexane, n-heptane, diethyl ether, petroleum ether, 1,4-dioxane, cyclohexanone, toluene or xylene.

In another embodiment, the process for preparation of co-crystal ofboscalid and a triazole comprises:

-   -   a) dissolving boscalid and a triazole in a suitable solvent;    -   b) altering the temperature to produce the co-crystal.

According to an embodiment the solvent can be selected from aliphaticalcohols, ketones, esters, ethers, polar protic solvents, polar aproticsolvents, halogenated solvents, aliphatic hydrocarbon, and aromatichydrocarbon.

According to an embodiment, the solvent can be selected from methanol,ethanol, isopropyl alcohol, acetone, dichloromethane, dichloroethane,dichloropropane, trichloroethane, chloroform, and ethyl acetate.

In a preferred embodiment of the present invention, the solvent isselected from dichloromethane or dichloroethane.

In another aspect of the present invention, the co-crystal of boscalidand a triazole may be prepared by grinding together boscalid and thetriazole. The process comprises:

-   -   a) admixing boscalid and a triazole;    -   b) optionally admixing solvent to the mixture; and    -   c) grinding or crushing or milling the mixture to obtain the        co-crystal.

According to an embodiment, the solvent can be selected from aliphaticalcohols, ketones, esters, ethers, polar protic solvents, polar aproticsolvents, halogenated solvents, aliphatic hydrocarbon, and aromatichydrocarbon.

According to an embodiment, the solvent can be selected from methanol,ethanol, isopropyl alcohol, acetone, dichloromethane, dichloroethane,dichloropropane, trichloroethane, chloroform, and ethyl acetate.

In an embodiment, the present invention provides agrochemicalcomposition comprising a co-crystal of boscalid and a triazole.

In an embodiment of the present invention, there is provided anagrochemical composition comprising the co-crystal of boscalid and atriazole along with other agronomically acceptable excipients.

In an embodiment of the present invention the process of adding theingredients/and or other pesticides can be in any order.

The agrochemical compositions comprising the co-crystal of boscalid anda triazole can be dispersible granules, wettable powders, solublepowders, dry flowables, emulsion, dispersion, suspension concentrate,encapsulation in polymeric materials, oil dispersions, emulsifiableconcentrate, soluble liquid concentrate, micro emulsions, flow ableconcentrate, or suspo-emulsion. These formulations are produced in aknown manner for example by mixing the co-crystal of boscalid and atriazole with auxiliaries suitable for the formulation of these activeingredients such as solvents/carriers, optionally with adjuvants such assurfactants, emulsifiers, dispersing agents, anti-foaming agents,anti-freezing agents, colorants, wetting agents, anticaking agents,biocides, viscosity modifiers and binding agents. The compositioncontent of these adjuvants is not particularly limiting and may bedetermined by a skilled technician in the art according to theconventional protocols.

In an embodiment of the present invention, the surfactants that can beadditionally added to the compositions are selected from nonionic and/oranionic surfactants.

Examples of nonionic surfactants comprise alkylphenol alkoxylates,alcohol alkoxylates, fatty amine alkoxylates, polyoxyethylene glycerolfatty acid esters, castor oil alkoxylates, fatty acid alkoxylates, fattyamide alkoxylates, fatty polydiethanolamides, lanolin ethoxylates, fattyacid polyglycol esters, isotridecyl alcohol, fatty amides,methylcellulose, fatty acid esters, alkyl polyglycosides, glycerol fattyacid esters, polyethylene glycol, polypropylene glycol, polyethyleneglycol/polypropylene glycol block copolymers, polyethylene glycol alkylethers, polypropylene glycol alkyl ethers, polyethyleneglycol/polypropylene glycol ether block copolymers (polyethyleneoxide/polypropylene oxide block copolymers) and mixtures thereof.Preferred nonionic surfactants are fatty alcohol ethoxylates, alkylpolyglycosides, glycerol fatty acid esters, castor oil alkoxylates,fatty acid alkoxylates, fatty amide alkoxylates, lanolin ethoxylates,fatty acid polyglycol esters and ethylene oxide/propylene oxide blockcopolymers and mixtures thereof.

Examples of anionic surfactants include alkylaryl sulfonates, phenylsulfonates, alkyl sulfates, alkyl sulfonates, aryl alkyl sulfonates,alkyl ether sulfates, alkylaryl ether sulfates, alkyl polyglycol etherphosphates, polyaryl phenyl ether phosphates, alkyl sulfosuccinates,olefin sulfonates, paraffin sulfonates, petroleum sulfonates, taurides,sarcosides, salts of fatty acids, alkylnaphthalenesulfonic acids,naphthalenesulfonic acids and lignosulfonic acids, condensates ofsulfonated naphthalenes with formaldehyde or with formaldehyde andphenol and, if appropriate, urea, and also condensates of phenolsulfonicacid, formaldehyde and urea, lignosulfite waste liquors andlignosulfonates, alkyl phosphates, alkylaryl phosphates, for exampletristyryl phosphates, and also polycarboxylates, such as, for example,polyacrylates, maleic anhydride/olefin copolymers, including the alkalimetal, alkaline earth metal, ammonium and amine salts of the substancesmentioned above and mixtures thereof. Preferred anionic surfactants arethose which carry at least one sulfonate group, and in particular theiralkali metal and their ammonium salts and mixtures thereof.

In an embodiment of the present invention, solvents suitable for use inthe compositions of the present invention include water, aromaticsolvents (for example Solvesso products, xylene, mix-xylene), alcohols(for example methanol, butanol, pentanol, benzyl alcohol), ketones (forexample cyclohexanone, gamma-butyrolactone), pyrrolidones (NMP, NOP),ketonic solvents, glycols, acetates (glycol diacetate), carbonates suchas propylene carbonates, fatty acid dimethylamides (for example N, Ndimethyl octanamide, N, N dimethyl decanamide, Hallcomid, rhodiasolvadma10, fatty acids fatty acid esters and amino carboxylic acid esters(polarclean). In principle, solvent mixtures can also be used.

In an embodiment the compositions of the present invention comprise acrystallisation inhibitor which is usually employed for this purpose inagrochemical compositions.

In an embodiment of the present invention, the compositions compriserheology modifier (or a viscosity modifying additive or a structuringagent). Suitable compounds are all those compounds usually employed forthis purpose in agrochemical compositions. Examples include bentonites,attapulgites, polysaccharides, such as xanthan gum and kelzan gum.

In another embodiment of the present invention, the compositionscomprise antifreeze agents. Suitable antifreeze agents are liquidpolyols, for example ethylene glycol, propylene glycol or glycerol.

Common surface-active substances present in formulations of agrochemicalactive ingredients are suitable for use as emulsifiers. Examples areethoxylated nonylphenols, polyethylene glycol ethers of linear alcohols,conversion products of alkylphenols with ethylene oxide and/or propyleneoxide, ethylene oxide-propylene oxide block copolymers, polyethyleneglycols and polypropylene glycols (Emulsogen PC), furthermore fatty acidesters, alkyl sulphonates, alkyl sulphates, aryl sulphates, ethoxylatedarylalkylphenols, such as tristyryl-phenol-ethoxylate, furthermoreethoxylated and propoxylated arylalkylphenols as well as sulphated orphosphated arylalkylphenol-ethoxylates or -ethoxy- and —propoxylates.

In yet another embodiment of the present invention, the compositionscomprise dispersing agents. All substances commonly used as dispersingagents in plant protection products are suitable for this purpose.Preferred dispersants are of anionic or nonionic nature and selected,for example, from polyethylene glycol/polypropylene glycol blockcopolymers, polyethylene glycol alkyl ethers, polypropylene glycol alkylethers, polyethylene glycol/polypropylene glycol ether block copolymers,alkylaryl phosphates, for example tristyryl phosphates, lignosulfonicacids, condensates of sulfonated naphthalenes with formaldehyde or withformaldehyde and phenol and, if appropriate, urea, and also condensatesof phenolsulfonic acid, formaldehyde and urea, lignosulfite wasteliquors and lignosulfonates, polycarboxylates, such as, for example,polyacrylates, maleic anhydride/olefin copolymers including the alkalimetal, alkaline earth metal, ammonium and amine salts of the substancesmentioned above.

In another embodiment of the present invention, the compositionscomprise wetting agents. Preferred wetting agents are of anionic ornonionic nature and selected, for example, from naphthalenesulfonicacids including their alkali metal, alkaline earth metal, ammonium andamine salts, fatty alcohol ethoxylates, alkyl polyglycosides, glycerolfatty acid esters, castor oil alkoxylates, fatty acid alkoxylates, fattyamide alkoxylates, fatty polydiethanolamides, lanolin ethoxylates andfatty acid polyglycol esters.

In an embodiment of the present invention the compositions comprise ahumectant selected from polyols like sucrose, glycerin or glycerol,triethylene glycol, tripropylene glycol, and propylene glycol.

In an embodiment there is provided a process for the preparation ofcompositions comprising of co-crystal of boscalid and a triazole andagronomically acceptable excipients. The process for preparing suchcompositions is not particularly limiting.

In an embodiment of the present invention, the composition of co-crystalof boscalid and a triazole is be prepared by a process comprising:

-   -   a) mixing boscalid and a triazole with at least one        agronomically acceptable excipient;    -   b) Optionally adding one or more other pesticides;    -   c) Optionally grinding and pulverizing; and    -   d) granulating said mixture to obtain granular composition.

In a preferred embodiment of the present invention, the agrochemicalcomposition comprises from about 0.1% to about 100% by weight of theco-crystal of boscalid and a triazole.

The step of granulating the mixture is not particularly limiting.Appropriate granulating processes are all conventional processesdescribed in granulating technology for example spray drying, fluidizedbed granulation, agglomeration, pan granulation and in particularextrusion granulation.

The co-crystal of boscalid and a triazole can be combined with one ormore other pesticides to form agrochemical compositions.

In an embodiment, the composition comprises administering the co-crystalof boscalid and a triazole along with one or more other pesticides.

In an embodiment, the one or more pesticide may be selected from:

-   -   a) herbicides selected from a isoxazolidinone herbicide, a urea        herbicide, a triazine herbicide, a hydroxybenzonitrile        herbicide, a thiocarbamate herbicide, a pyridazine herbicide,        chloroacetanilide herbicides; benzothiazole herbicides;        carbanilate herbicides, cyclohexene oxime herbicides; picolinic        acid herbicides; pyridine herbicides; quinolinecarboxylic acid        herbicides; chlorotriazine herbicides, aryloxyphenoxypropionic        herbicides, oxadiazolone herbicides; phenylurea herbicides,        sulfonanilide herbicides; triazolopyrimidine herbicides, amide        herbicides, pyridazine herbicides, dinitroaniline herbicides or        combinations thereof;    -   b) fungicides selected from amide fungicides, acylamino acid        fungicides, anilide fungicides, benzamide fungicides,        sulfonamide fungicides, strobilurin fungicides, aromatic        fungicides, benzimidazole fungicides, carbamate fungicides,        carbanilate fungicides, conazole fungicides (imidazoles        triazoles), copper fungicides, dithiocarbamate fungicides,        imidazole fungicides, organophosphorus fungicides, oxazole        fungicides, pyrazole fungicides, pyridine fungicides or        combinations thereof; and    -   c) insecticides selected from arsenical insecticides, botanical        insecticides, carbamate insecticides, benzofuranyl        methylcarbamate insecticides, dimethylcarbamate insecticides,        insecticides, dinitrophenol insecticides, fluorine insecticides,        formamidine insecticides, fumigant insecticides, inorganic        insecticides, insect growth regulators, benzoylphenylurea chitin        synthesis inhibitors, macrocyclic lactone insecticides,        neonicotinoid insecticides, nereistoxin analogue insecticides,        organochlorine insecticides, organophosphorus insecticides,        organothiophosphate insecticides, heterocyclic        organothiophosphate insecticides, phenyl organothiophosphate        insecticides, phosphonate insecticides, phosphonothioate        insecticides, phosphoramidate insecticides, phosphoramidothioate        insecticides, phosphorodiamide insecticides, oxadiazine        insecticides, oxadiazolone insecticides, phthalimide        insecticides, physical insecticides, pyrazole insecticides,        pyrethroid insecticides, pyrethroid ether insecticides,        pyrimidinamine insecticides, pyrrole insecticides, quaternary        ammonium insecticides, sulfoximine insecticides, tetramic acid        insecticides, tetronic acid insecticides, thiazole insecticides,        thiazolidine insecticides and thiourea insecticides.

The co-crystal of boscalid and a triazole of the present invention issuitable for combating or controlling fungi. Accordingly, there isprovided a method of combating or controlling fungi, the methodcomprising contacting fungi or their locus with a fungicidally effectiveamount of co-crystal of boscalid and a triazole.

In an embodiment, the agrochemical compositions of the invention can beused to control various fungi species for example, Cochliobolus sativus,Erysiphe graminis, Leptosphaeria nodorum, Puccinia spp., Pyrenophoraspp., Rhynchosporium secalis, Septoria spp, Rhizoctonia solani,Helminthosporium oryzae, Hemileia vastatrix, Cercospora spp., Moniliniaspp., Podosphaera spp., Sphaerotheca spp., Tranzschelia spp., Alternariaspp., Aphanomyces spp., Ascochyta spp., Bipolaris and Drechslera spp.,Blumeria graminis spp., Botrytis cinerea, Botryodiplodia spp., Bremialactucae, Corynespora spp., Colletotricum spp., Curvularia spp.,Diplodia spp., Exserohilum spp., Fusarium spp., Verticillium spp.,Gaeumanomyces Gibberella spp., Macrophomina spp., Michrodochium spp,Mycosphaerella spp., Phaeoisaripsis spp. Phakopsara spp., Phoma spp.,Phytophthora spp., Plasmopara viticola, Penecilium spp.,Pseudocercosporella herpotrichoides spp., Pseudoperonospora spp.,Pyricularia oryzae, Corticium sasakii, Sarocladium oryzae, S.attenuatum, Entyloma oryzae, Pyriculana grisea, Pythium spp.,Thievaliopsis spp., Tilletia spp., Ustilago spp., Venturia spp.

The agrochemical compositions of the present invention are suitable forcontrolling such disease on a number of plants and their propagationmaterial including, but not limited to the following target crops:cereals (wheat, barley, rye, oats, maize (including field corn, pop cornand sweet corn), rice, sorghum and related crops); beet (sugar beet andfodder beet); leguminous plants (beans, lentils, peas, soybeans); oilplants (rape, mustard, sunflowers); cucumber plants (marrows, cucumbers,melons); fibre plants (cotton, flax, hemp, jute); vegetables (spinach,lettuce, asparagus, cabbages, carrots, eggplants, onions, pepper,tomatoes, potatoes, paprika, okra); plantation crops (bananas, fruittrees, rubber trees, tree nurseries), ornamentals (flowers, shrubs,broad-leaved trees and evergreens, such as conifers); as well as otherplants such as vines, bushberries (such as blueberries), caneberries,cranberries, peppermint, rhubarb, spearmint, sugar cane and turf grassesincluding, but not limited to, cool-season turf grasses (for example,bluegrasses (Poa L.), such as Kentucky bluegrass (Poa pratensis L.),rough bluegrass (Poa trivialis L.), Canada bluegrass (Poa compressa L.)and annual bluegrass (Poa annua L.); bentgrasses (Agrostis L.), such ascreeping bentgrass (Agrostis palustris Huds.), colonial bentgrass(Agrostis tenius Sibth.), velvet bentgrass (Agrostis canina L.) andredtop (Agrostis alba L.); fescues (Festuca L.), such as tall fescue(Festuca arundinacea Schreb.), meadow fescue (Festuca elatior L.) andfine fescues such as creeping red fescue (Festuca rubra L.), chewingsfescue (Festuca rubra var. commutata Gaud.), sheep fescue (Festuca ovinaL.) and hard fescue (Festuca longifolia); and ryegrasses (Lolium L.),such as perennial ryegrass (Lolium perenne L.) and annual (Italian)ryegrass (Lolium multiflorum Lam.)) and warm-season turf grasses (forexample, Bermudagrasses (Cynodon L. C. Rich), including hybrid andcommon Bermudagrass; Zoysiagrasses (Zoysia Willd.), St. Augustinegrass(Stenotaphrum secundatum (Walt.) Kuntze); and centipedegrass (Eremochloaophiuroides (Munro.) Hack.).

The methods of application of present invention can be of either apre-mix or tank mix of active ingredients with auxiliaries suitable forthe formulation or it can be a sequential application of one after theother.

The present invention will now be described by way of the followingnon-limiting examples and figures.

The invention shall now be described with reference to the followingspecific examples. It should be noted that the examples appended belowillustrate rather than limit the invention and that those skilled in theart will be able to design many alternative embodiments withoutdeparting from the scope of the present invention.

Example 1: Preparation of the Co-Crystal of Boscalid and Tebuconazole ofthe Present Invention by Crystallization and Precipitation byAnti-Solvent

300.0 g of boscalid and 270.0 g of tebuconazole were charged into aglass kettle. To this mixture was added 2992 g of dichloroethane. Theslurry was heated to 40-45° C. for 10 to 12 hours. Solvent wasevaporated under reduced pressure at 40-45° C. Hexane (400.0 g) wasadded to the reduced mass and the mixture was stirred for 30 min at30-35° C., to precipitate the product. The precipitated product wasfiltered and dried to obtain 566 g of white solid. The melting point ofsolid as recorded by DSC exhibits endothermic peak at 90.01° C.

The compound was analysed by HPLC for determining the molar ratio ofboscalid and tebuconazole in the co-crystal (FIG. 5 ).

The molar ratio of boscalid: tebuconazole in the co-crystal is found tobe 50.58:48.92.

Example 2: Preparation of the Co-Crystal of Boscalid and Hexaconazole ofthe Present Invention by Crystallization and Precipitation byAnti-Solvent

20.0 g of boscalid and 18.0 g of hexaconazole were charged into a glasskettle. To this mixture was added 200 g of dichloroethane. The slurrywas heated to 40-45° C. for 10 to 12 hours. Solvent was evaporated underreduced pressure at 40-45° C. Hexane (100.0 g) was added to the reducedmass and the mixture was stirred for 30 min at 30-35° C., to precipitatethe product. The precipitated product was filtered and dried to obtain37.2 g of white solid. The melting point of solid as recorded by DSCexhibits endothermic peak at 103.4° C.

Example 3: Preparation of the Co-Crystal of Boscalid and Cyproconazoleof the Present Invention by Crystallization and Precipitation byAnti-Solvent

20.0 g of boscalid and 17.0 g of cyproconazole were charged into a glasskettle. To this mixture was added 200.0 g of dichloroethane. The slurrywas heated to 40-45° C. for 10 to 12 hours. Solvent was evaporated underreduced pressure at 40-45° C. Hexane (100.0 g) was added to the reducedmass and the mixture was stirred for 30 min at 30-35° C., to precipitatethe product. The precipitated product was filtered and dried to obtain36.1 g of white solid. The melting point of solid as recorded by DSCexhibits endothermic peak at 99.03° C.

Example 4: Preparation of the Co-Crystal of Boscalid and Tebuconazole ofthe Present Invention by Crystallization from Dichloroethane andEvaporation of Solvent

300.0 g of boscalid and 270.0 g of tebuconazole were taken into a glasskettle. To this mixture was added 2992 g of dichloroethane, the slurrywas heated to 40-45° C. for 10 to 12 hours. Solvent was evaporated underreduced pressure at 40-45° C. to obtain 564.4 g of white solid. Themelting point of solid as recorded by DSC exhibits endothermic peak at90.6° C.

Example 5: Preparation of the Co-Crystal of Boscalid and Tebuconazole ofthe Present Invention by Neat Grinding

300.0 g of boscalid and 270.0 g of tebuconazole were charged in anelectric grinder. The mixture was grinded for 5 min at room temperatureto obtain 567.5 g of white solid. The melting point of solid as recordedby DSC exhibits endothermic peak at 96.75° C.

Example 6: Preparation of the Co-Crystal of Boscalid and Tebuconazole ofthe Present Invention by Solvent Drop Grinding Technique

1.11 g of boscalid and 1.0 g of tebuconazole were weighed andtransferred into a mortar. The solids were wetted with 100 μL ofmethanol, and hand-ground with a pestle until a dried solid crystallinemass was obtained. The melting point of the solid as recorded by DSCexhibits endothermic peak at 95.72° C.

Example 7: Preparation of the Co-Crystal of Boscalid and Tebuconazole ofthe Present Invention in Formulation Composition

Boscalid, tebuconazole, sodium lignosulphonate and kaolin were weighedand manually mixed. This mixture was air jet milled up to desiredparticle size. The mixture was kneaded to dough by adding demineralizedwater. The dough was extruded on screw extruder and dried at 55° C. influid bed dryer up to moisture content below 1.5%.

TABLE 1 BOSCALID AND TEBUCONAZOLE WATER DISPERSIBLE GRANULE COMPOSITIONSr. No. Material % w/w 1. Boscalid 35.02 2. Tebuconazole 31.73 3. Sodiumlignosulphonate 21.00 4. Kaolin, QS 13.25 Total 100.00

The differential thermal analysis thermogram of the formulationexhibited endothermic peak at 94.5° C.

Example 8: SC Formulation of Co-Crystal of Boscalid and Tebuconazole

Co-crystal of boscalid and tebuconazole, sulfonated aromatic polymersodium salt, propylene glycol, silicon defoamer were taken in a beakerand kept under homogenizer to form homogenous slurry. This slurry wasjet milled with dyno mill up to desired particle size. Xanthan gum wasadded to this wet milled slurry under homogenization. The slurry wasstirred till it formed homogeneous suspension concentrate.

TABLE 2 COMPOSITION OF BOSCALID AND TEBUCONAZOLE 44.08% SUSPENSIONCONCENTRATE Sr. No. Material % w/w 1. Co-crystal of boscalid andtebuconazole 44.08 2. Sulfonated aromatic polymer, sodium salt 7.00 3.Propylene glycol 5.00 4. Silicon Defoamer 0.55-1.05 5. Xanthan Gum0.2-0.4 6. Demineralized Water, QS 42.47-43.17 Total 100.00

Example 9: Tebuconazole SC Formulation (Comparative Example)

Tebuconazole, sulfonated aromatic polymer sodium salt, propylene glycol,silicon defoamer were taken in a beaker and kept under homogenizer toform homogenous slurry. This slurry was jet milled with dyno mill up todesired particle size. Xanthan gum was added to this wet milled slurryunder homogenization. The slurry was stirred till it forms homogeneoussuspension concentrate.

TABLE 3 COMPOSITION FOR TEBUCONAZOLE 38.7% SC Sr. No. Material % w/w 1.Tebuconazole 39.89 2. Sulfonated aromatic polymer, sodium salt 3.50 3.Propylene glycol 5.00 4. Silicon defoamer 0.55-1.05 5. Xanthan Gum0.2-0.4 6. Demineralized Water, QS 50.16-50.86 Total 100.00

Example 10: Particle Size Distribution Study

The particle size distribution was studied for SC formulation ofboscalid tebuconazole co-crystal (Example 8) and SC formulation oftebuconazole (Example 9). The dispersion of boscalid and tebuconazole SCwas analyzed by laser particle size analyzer (Malvern Mastersizer2000SM) on a 100-fold dilution in water as given in Table 4 to measurethe particle size distribution. The sample was kept for 14 days atelevated temperature. After completion of 14 days the particle sizedistribution were measured.

In similar manner dispersion of tebuconazole SC were analyzed to measureparticle size distribution. The results are given in Table 4.

TABLE 4 PARTICLE SIZE DISTRIBUTION STUDY OF TEBUCONAZOLE SUSPENSIONCONCENTRATE FORMULATION AND BOSCALID TEBUCONAZOLE SC FORMULATIONParticle size in micron At ambient At ambient temperature At 54° C.temperature At 54° C. Particle size on 0 day on 14^(th) day on 0 day on14^(th) day distribution Boscalid tebuconazole SC Tebuconazole SC d₅₀2.073 2.265 1.950 3.615 d₉₀ 3.611 4.215 3.321 9.572

Particle size of boscalid and tebuconazole co-crystal dispersion was notincreased significantly after 14 days at elevated temperature ascompared with tebuconazole dispersion. Hence it is concluded thatcrystal growth in tebuconazole suspension concentrate formulation duringstorage is controlled by co-crystal of boscalid and tebuconazole ascomprehended from the results described in Table 4.

DESCRIPTION OF THE ACCOMPANYING DRAWINGS

FIG. 1 shows a DSC trace of co-crystal of boscalid and tebuconazoleobtained using the process described in Example 1.

FIG. 2 shows a DSC trace of boscalid and hexaconazole co-crystalobtained using the process described in Example 2.

FIG. 3 shows a DSC trace of boscalid and cyproconazole co-crystalobtained using the process described in Example 3.

FIG. 4 shows a DSC trace of co-crystal of boscalid and tebuconazoleobtained using the process described in Example 7.

FIG. 5 shows the HPLC chromatogram of co-crystal of boscalid andtebuconazole obtained using the process described in Example 1.

While the foregoing written description of the invention enables one ofordinary skill to make and use what is considered presently to be thebest mode thereof, those of ordinary skill will understand andappreciate the existence of variations, combinations, and equivalents ofthe specific embodiment, method, and examples herein. The inventionshould therefore not be limited by the above described embodiment,method, and examples, but by all embodiments and methods within thescope and spirit of the invention.

1. A co-crystal of boscalid and hexaconazole or cyproconazole.
 2. Theco-crystal of claim 1 comprising boscalid and hexaconazole, wherein themelting point of the co-crystal is in the range of 101-105° C. whenmeasured with a Differential Scanning calorimeter.
 3. The co-crystal ofclaim 1 comprising boscalid and cyproconazole, wherein the melting pointof the co-crystal is in the range of 97-101° C. when measured with aDifferential Scanning calorimeter.
 4. The co-crystal of claim 1, wherein the molar ratio of boscalid to hexaconazole or cyproconazole is inthe range of 3:1 to 1:3.
 5. The co-crystal of claim 1, where in themolar ratio of boscalid to hexaconazole or cyproconazole is 1:1.
 6. Anagrochemical composition comprising the co-crystal of claim 1 and anagronomically acceptable excipient.
 7. A method of combating orcontrolling fungi, said method comprising contacting fungi or theirlocus with a fungicidally effective amount of the co-crystal of claim 1.